Although rapidly rising mortgage rates, combined with persistently high housing prices, have become one of the biggest factors holding back home buying, the list is much longer. Chief among these are increased borrowing costs associated with regulatory risk, risk insurance and national regulations. The uncertainty that comes with regulatory risk plays a major role in …
Counterfeit versions of Eli Lilly’s retatrutide, hailed as a potential “new Ozempic,” are being sold directly to U.S. consumers through Chinese websites, although regulatory approval remains years away. Hundreds of marketers are offering the new drug to buyers in the United States through websites such as Made-in-China.com and GorillaHealing.com, the Wall Street Journal reports. Some …
Dr. Frances Oldham Kelsey had only been working at the Food and Drug Administration for about a month when she was assigned to review a drug called thalidomide for distribution in America. Marketed as a sedative for pregnant women, thalidomide was already available in Canada, Germany and several African countries. This could have been a …